Company intelligence / Profile preview

Rodenstock

Munich, Bavaria, Germanyrodenstock.com ↗

Ownership: Private
Employees: ~4900
Development stage: Commercial

Overview

Rodenstock has commercialized a range of innovative spectacle lenses using advanced biometric measurements to provide individualized vision correction solutions. Their DNEye Pro and B.I.G. VISION™ technologies are market-leading in the field of ophthalmic optics.

Therapeutic areas: Ophthalmology
Modalities: Device (spectacle lenses)Diagnostic device (biometric eye measurement)
Industry: Assistive Medical Devices

Partnerships

Porsche Design eyewear collaboration

Beyond the preview

Go deeper on Rodenstock.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rodenstock.

Explore the full profile